Transplants for myocardial scars

Abstract

A method is provided for forming a graft in heart tissue which comprises the transplantation of cells chosen from cardiomyocytes, fibroblasts, smooth muscle cells, endothelial cells and skeletal myoblasts. The grafts are especially useful in treating scar tissue on the heart.

1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . A method of forming a stable cardiac graft in a mammal, said method comprising transplanting endothelial cells into scar tissue in said mammal's heart, wherein said transplanted endothelial cells improve heart function in said mammal. 
     
     
         8 . The method of  claim 1 , wherein said graft is used for cardiomyoplasty. 
     
     
         9 . The method of  claim 1 , wherein said graft is used for closing cardiac defects. 
     
     
         10 . The method of  claim 1 , wherein said graft is used for myocardial reconstructive surgery. 
     
     
         11 . A method for improving heart function in a mammal with myocardial injury, comprising the step of transplanting endothelial cells into said mammal's heart, wherein said endothelial cells are transplanted into said mammal's heart after fibrotic tissue has formed in response to said injury, and wherein said transplanted endothelial cells improve heart function in said mammal. 
     
     
         12 . A method for improving heart function in a mammal with heart damage due to acute myocardial injury, comprising the step of transplanting endothelial cells into said mammal's heart, wherein said endothelial cells are transplanted into said mammal's heart after an inflammatory response to said acute myocardial injury has subsided and wherein said transplanted endothelial cells improve heart function in said mammal. 
     
     
         13 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are autologous to the mammal being treated. 
     
     
         14 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are allogeneic to the mammal being treated. 
     
     
         15 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are administered by direct injection into said mammal's heart. 
     
     
         16 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are transfected to deliver recombinant molecules to said mammal's heart. 
     
     
         17 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are supported on a biodegradable or non-biodegradable scaffolding. 
     
     
         18 . The method of any one of  claims 7 ,  11 , or  12 , wherein said endothelial cells are obtained from skin biopsy. 
     
     
         19 . The method of any one of  claims 7 ,  11 , or  12 , further comprising culturing said endothelial cells prior to transplanting.